"Botulinum Toxins, Type A" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A serotype of botulinum toxins that has specificity for cleavage of SYNAPTOSOMAL-ASSOCIATED PROTEIN 25.
| Descriptor ID |
D019274
|
| MeSH Number(s) |
D08.811.277.656.300.480.153.100 D08.811.277.656.675.374.153.100 D12.776.097.156.100 D23.946.123.179.050
|
| Concept/Terms |
Botulinum Toxins, Type A- Botulinum Toxins, Type A
- Botulinum Neurotoxin A
- Neurotoxin A, Botulinum
- Clostridium botulinum A Toxin
- Clostridium Botulinum Toxin Type A
- Botulinum A Toxin
- Toxin, Botulinum A
- Botulinum Toxin Type A
|
Below are MeSH descriptors whose meaning is more general than "Botulinum Toxins, Type A".
Below are MeSH descriptors whose meaning is more specific than "Botulinum Toxins, Type A".
This graph shows the total number of publications written about "Botulinum Toxins, Type A" by people in this website by year, and whether "Botulinum Toxins, Type A" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 3 | 0 | 3 |
| 2017 | 10 | 1 | 11 |
| 2018 | 14 | 3 | 17 |
| 2019 | 6 | 4 | 10 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Botulinum Toxins, Type A" by people in Profiles.
-
Commentary on: A Randomized, Single-Blind, Crossover Study Evaluating the Impact of OnabotulinumtoxinA Treatment on Mood and Appearance During the COVID-19 Pandemic. Aesthet Surg J. 2021 08 13; 41(9):NP1206-NP1207.
-
A Randomized, Single-Blind, Crossover Study Evaluating the Impact of OnabotulinumtoxinA Treatment on Mood and Appearance During the COVID-19 Pandemic. Aesthet Surg J. 2021 08 13; 41(9):NP1199-NP1205.
-
Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown. Neurol Sci. 2021 Dec; 42(12):5087-5092.
-
Should the Private Physiotherapeutic Units Stay Open During the Pandemic Crisis of COVID-19? Am J Phys Med Rehabil. 2021 03 01; 100(3):213.
-
The Impact of SARS-CoV-2 Pandemic Lockdown on a Botulinum Toxin Outpatient Clinic in Germany. Toxins (Basel). 2021 01 29; 13(2).
-
Botulinum toxin as an ultrasensitive reporter for bacterial and SARS-CoV-2 nucleic acid diagnostics. Biosens Bioelectron. 2021 Mar 15; 176:112953.
-
Severe hyperalgesia and pain during botulinum toxin injection avoiding application in a patient 1 week after COVID-19 infection. J Cosmet Dermatol. 2021 Mar; 20(3):755-756.
-
Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity. Eur J Phys Rehabil Med. 2021 Jun; 57(3):424-433.
-
Botulinum toxin therapy during the COVID-19 outbreak: Experience of an Italian multidisciplinary team. Eur J Neurol. 2021 10; 28(10):e71-e72.
-
Hospital-based headache care during the Covid-19 pandemic in Denmark and Norway. J Headache Pain. 2020 Oct 29; 21(1):128.